Click Therapeutics
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Click Therapeutics sits in the top decile of US sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count).
Click Therapeutics: 15 sponsored US clinical trials, none currently recruiting.
Click Therapeutics sponsors 15 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 15 completed. 3 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Headache, Migraine, with 2 trials.
Top-decile sponsor footprint
Click Therapeutics ranks in the top decile of sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
15 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
15 total, page 1 of 1
An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-156 in People with Schizophrenia.
NCT06486948
An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis
NCT06275659
An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer
NCT06136923
A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia
NCT06136936
An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia
NCT06067984
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)
NCT06004388
Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia
NCT05838625
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine
NCT05853900
Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training
NCT05573685
7-week Study With CT-155 in People With Schizophrenia
NCT05486312
Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms
NCT05438147
Exploratory Study of a Digital Therapeutics in People With Schizophrenia
NCT05438160
Clinical Learning Study for a Mobile Smoking Cessation Program
NCT04857515
Ecological Momentary Assessment and Text Message Intervention for Stress Management
NCT04907942
Clinical Trial of Smoking Cessation Mobile Phone Program
NCT02656745
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 3 |
Therapeutic Areas
How the Click Therapeutics archive is shaped
15 indexed studies, none listed as recruiting (0% open); 15 completed (100%).
Phase mix: 3 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Headache, Migraine (2 trials), 8 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Click Therapeutics: archived-pipeline peers nationwide
Peers matched on 15 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Click Therapeutics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 15 archived trials
- Allakos · 15 trials · 0% recruiting
- Arbor Research Collaborative for Health · 15 trials · 33% recruiting
- Arena Pharmaceuticals · 15 trials · 0% recruiting
- Arrowhead Pharmaceuticals · 15 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Click Therapeutics page
15 registered trials is a research-attention snapshot, not an endorsement of Click Therapeutics or any single study.
- None of Click Therapeutics's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Headache, Migraine is the condition Click Therapeutics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Headache, Migraine trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Click Therapeutics pipeline card: 15 registered trials from official public datasets.Report a data error.